A one-pot assembly of 4-allyl-3-pyridinecarboxaldehyde. A new synthesis of 1-methyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,2-f]pyrindine, an annulated nicotine analogue

doi:10.1016/J.TET.2004.04.069

Paper

DOI: 10.1016/J.TET.2004.04.069

A one-pot assembly of 4-allyl-3-pyridinecarboxaldehyde. A new synthesis of 1-methyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,2-f]pyrindine, an annulated nicotine analogue

Published Jun 14, 2004 · Shengjun Luo, F. Fang, Mingyue Zhao

Tetrahedron

Q3 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

This study presents a two-step synthesis of 1-methyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,2-f]pyrindine, a conformationally constrained nicotine analogue, using a single-step process.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1021/JA034805T

A new strategy for improved nicotine vaccines using conformationally constrained haptens.

Constrained nicotine analogues coupled to KLH show highly increased antibody titers and affinity for nicotine compared to flexible nicotine haptens.

2003·54citations·M. Meijler et al.·Journal of the American Chemical Society

Journal of the American Chemical Society

DOI: 10.1021/OL026876N

A facile synthesis of cis-1-methyl-1,2,3,3a,4,8b- hexahydropyrrolo[3,2-f]pyrindine, an annulated nicotine analog.

This study presents a facile method for synthesizing cis-1-methyl-1,2,3,3a,4,8b-hexahydropyrrolo[3,2-f]pyrindine, an annulated nicotine analog, in 45% overall yield from 3-bromopyridine.

2002·13citations·H. Zhai et al.·Organic letters

Organic letters

DOI: 10.1517/13543784.10.10.1819

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

Nicotinic acetylcholine receptor agonists show potential as highly efficacious treatments for various pain states, with ABT-594 currently in Phase II clinical evaluation.

2001·124citations·M. Decker et al.·Expert Opinion on Investigational Drugs

Expert Opinion on Investigational Drugs

DOI: 10.1021/JO010534Y

Enantiospecific synthesis of annulated nicotine analogues from D-glutamic acid. 7-Azabicyclo[2.2.1]heptano[2.3-c]pyridines.

This study demonstrates an enantiospecific synthesis of nicotinoid analogues from D-glutamic acid, providing a potential method for the synthesis of nicotine-like compounds.

2001·23citations·J. R. Lennox et al.·The Journal of organic chemistry

The Journal of organic chemistry

DOI: 10.1016/S0006-3223(00)01125-2

Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implications

Nicotinic receptor abnormalities in Alzheimer's disease patients suggest potential targets for drug intervention, with cholinergic drugs showing improvement in brain function.

2001·344citations·A. Nordberg·Biological Psychiatry

Biological Psychiatry

DOI: 10.1002/CHIN.200114147

Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors.

The 6-carbamate 4 is nearly as potent as physostigmine as an acetylcholinesterase inhibitor, with a similar time-dependent pattern observed for 3 and 4.

2001·24citations·M. Bolognesi et al.·Journal of medicinal chemistry

Journal of medicinal chemistry

DOI: 10.1016/S0301-0082(99)00045-3

Neuronal nicotinic receptors in the human brain

Neuronal nicotinic acetylcholine receptors (nAChRs) play a diverse role in the human brain, mediating nicotine effects and implicated in various neuropathological conditions.

2000·796citations·David Paterson et al.·Progress in Neurobiology

Progress in Neurobiology

DOI: 10.1016/S0014-2999(00)00066-2

Neuronal nicotinic receptors, important new players in brain function.

Neuronal nicotinic receptors play a crucial role in brain function, with their structural complexity influencing their pharmacological and biophysical properties.

2000·117citations·Francesco Clementi et al.·European journal of pharmacology

European journal of pharmacology

DOI: 10.1021/JO991383Q

A computational study of nicotine conformations in the gas phase and in water.

Nicotine's most stable conformation is the N-methyl trans species in both gas phase and aqueous solution, with the cis/trans energy gap reduced in water and pyridine ring rotamers experiencing different solvation energies.

2000·55citations·D. Elmore et al.·The Journal of organic chemistry

The Journal of organic chemistry

Citations

DOI: 10.3390/molecules26247544

Synthetic Methods for the Preparation of Conformationally Restricted Analogues of Nicotine

Synthetic methods for conformationally restricted analogues of nicotine show promise as promising drug molecules for selective nAChR-targeting ligands.

2021·2citations·Biswajit Panda et al.·Molecules

Molecules

DOI: 10.1016/J.TETLET.2007.12.066

A facile synthesis of chromeno[4,3-b]pyrroles derived from allyl derivatives of Baylis–Hillman adducts through intramolecular 1,3-dipolar cycloaddition using ultrasonication

Ultrasonication improves the synthesis of chromeno[4,3-b]pyrroles from Baylis-Hillman adducts by intramolecular 1,3-dipolar cycloaddition.

2008·32citations·E. Ramesh et al.·Tetrahedron Letters

Tetrahedron Letters

DOI: 10.1002/047084289X.RC224.PUB2

Copper(I) Cyanide

Copper(I) cyanide is a highly toxic compound, and proper handling and storage are crucial for its safe use in various chemical reactions.

2006·2citations·S. Bertz et al.

DOI: 10.1016/J.TET.2005.12.032

Synthesis of conformationally restricted nicotine analogues by intramolecular [3+2] cycloaddition

This study presents a general method for rapidly assembling related tricyclic nicotine analogues, with potential applications in developing selective nAChRs-targeting ligands.

2006·16citations·Xiaobao Yang et al.·Tetrahedron

Tetrahedron

DOI: 10.1016/J.BMCL.2004.12.069

6′-Methylpyrido[3,4- b ]norhomotropane: synthesis and outstanding potency in relation to the α4β2 nicotinic receptor pharmacophore model

6′-Methylpyrido[3,4-b]norhomotropane is more potent at the 42 nicotinic receptor than any previous bridged nicotinoid, with its structure suggesting it may be equivalent to acetyl methyl

2005·7citations·D. Kanne et al.·Bioorganic & Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters